RemeGen Co., Ltd. (HKG:9995)
Hong Kong
· Delayed Price · Currency is HKD 88.35
-1.35 (-1.51%)
At close: Dec 5, 2025
RemeGen Market Cap
RemeGen has a market cap or net worth of 55.46 billion as of December 5, 2025. Its market cap has increased by 248.55% in one year.
Market Cap
55.46B
Enterprise Value
56.55B
Revenue
2.43B
Ranking
n/a
PE Ratio
n/a
Stock Price
88.35
Market Cap Chart
Since November 9, 2020, RemeGen's market cap has increased from 33.39B to 55.46B, an increase of 66.09%. That is a compound annual growth rate of 10.52%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Dec 5, 2025 | 55.46B | 295.99% |
| Dec 31, 2024 | 14.00B | -55.02% |
| Dec 29, 2023 | 31.13B | -25.43% |
| Dec 30, 2022 | 41.75B | 9.42% |
| Dec 31, 2021 | 38.16B | -18.00% |
| Dec 31, 2020 | 46.53B | 39.37% |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| BeOne Medicines AG | 285.39B |
| Hansoh Pharmaceutical Group Company | 244.94B |
| JD Health International | 192.57B |
| Innovent Biologics | 160.32B |
| WuXi Biologics | 135.64B |
| Sino Biopharmaceutical | 122.99B |
| Akeso | 113.67B |
| Sichuan Kelun-Biotech Biopharmaceutical | 104.70B |